Preview

Obesity and metabolism

Advanced search

Hypercalciuria and hyperparathyroidism — is there always a connection?

https://doi.org/10.14341/omet12788

Abstract

Hypercalciuria is a pathological condition characterized by an excess of daily calcium excretion. A high concentration of urine calcium can initiate stone formation. There are several types of hypercalciuria, each requires an individual approach. In the absence of known causes of development, idiopathic hypercalciuria is a frequent dysmetabolic disorder defined as an excess urine calcium excretion with normocalcemia. Resorptive hypercalciuria most often develops due to primary hyperparathyroidism and is caused by elevated PTH and excess release of calcium from bone stores. A thiazide test can be used for differential diagnosis between these conditions. We present a series of clinical cases covered the thiazide test in outpatient practice. The definitive diagnosis is extremely important because it determines the optimal treatment strategy. Secondary hyperparathyroidism (an increase in parathyroid hormone as a result of vitamin D deficiency, chronic renal failure or other conditions) requires medical therapy, while the primary hyperparathyroidism is radically cured only after surgical intervention.Taking into account the prevalence of idiopathic hypercalciuria and primary hyperparathyroidism, it is actual to use the thiazide test more widely in clinical practice.

 

About the Authors

S. S. Mirnaya
LLC «Set' semeinykh meditsinskikh tsentrov №1»
Russian Federation

Svetlana S. Mirnaya, MD, PhD

7-3-33 Korolenko street, 107076 Moscow

Scopus Author ID: 57191923409;

eLibrary SPIN: 1968-7706



A. K. Eremkina
Endocrinology Research Centre
Russian Federation

Anna K. Eremkina, MD, PhD

Moscow

eLibrary SPIN: 8848-2660



References

1. Golovanov SA, Sivkov AV, Anohin NV. Hypercalciuria: principles of differential diagnostics. Experimental and clinical urology 2015;4:86-92. (In Russ.).

2. Lerolle N, Lantz B, Paillard F, et al. Risk factors for nephrolithiasis in patients with familial idiopathic hypercalciuria. Am J Med. 2002;113(2):99-103. doi: https://doi.org/10.1016/s0002-9343(02)01152-x

3. Fink HA, Wilt TJ, Eidman KE, et al. Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline. Ann Intern Med. 2013;158(7):535-543. doi: https://doi.org/10.7326/0003-4819-158-7-201304020-00005

4. Ong GS, Walsh JP, Stuckey BG, et al. The importance of measuring ionized calcium in characterizing calcium status and diagnosing primary hyperparathyroidism. J Clin Endocrinol Metab. 2012;97(9):3138-3145. doi: https://doi.org/10.1210/jc.2012-1429

5. Bollerslev J, Schalin-Jäntti C, Rejnmark L, et al. Management of endocrine disease: Unmet therapeutic, educational and scientific needs in parathyroid disorders. Eur J Endocrinol. 2019;181(3):1-19. doi: https://doi.org/10.1530/EJE-19-0316

6. Li DF, Gao YL, Liu HC, et al. Use of thiazide diuretics for the prevention of recurrent kidney calculi: a systematic review and meta-analysis. J Transl Med. 2020;18(1):106. doi: https://doi.org/10.1186/s12967-020-02270-7

7. Eisner BH, Ahn J, Stoller ML. Differentiating primary from secondary hyperparathyroidism in stone patients: the «thiazide challenge». J Endourol. 2009;23(2):191-192. doi: https://doi.org/10.1089/end.2008.0567

8. Riss P, Kammer M, Selberherr A, et al. The influence of thiazide intake on calcium and parathyroid hormone levels in patients with primary hyperparathyroidism. Clin Endocrinol (Oxf ). 2016;85(2):196-201. doi: https://doi.org/10.1111/cen.13046

9. Tsvetov G, Hirsch D, Shimon I, et al. Thiazide Treatment in Primary Hyperparathyroidism-A New Indication for an Old Medication? J Clin Endocrinol Metab. 2017;102(4):1270-1276. doi: https://doi.org/10.1210/jc.2016-2481


Supplementary files

1. Рисунок 1. Механизм действия гидрохлортиазида
Subject
Type Исследовательские инструменты
View (188KB)    
Indexing metadata ▾

Review

For citations:


Mirnaya S.S., Eremkina A.K. Hypercalciuria and hyperparathyroidism — is there always a connection? Obesity and metabolism. 2022;19(1):92-95. (In Russ.) https://doi.org/10.14341/omet12788

Views: 10483


ISSN 2071-8713 (Print)
ISSN 2306-5524 (Online)